USPTO Says Patent Owners Are Jumping The Gun On Arthrex

Law360 (July 21, 2021, 7:12 PM EDT) -- The U.S. Patent and Trademark Office told the Federal Circuit on Wednesday that it's too soon for two patent owners to challenge the agency's plans to have its acting director review rulings following the Arthrex decision, and they should wait until remanded proceedings at the agency are complete.

The office shot back against an argument from card game developer New Vision Gaming & Development Inc. and patent licensing business Mobility Workx LLC that the agency's commissioner for patents, Drew Hirshfeld, can't conduct reviews required under the U.S. Supreme Court's Arthrex ruling.

The day before, the USPTO laid out additional guidance for...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!